- CA$16.42bn
- CA$18.73bn
- $4.24bn
- 80
- 47
- 95
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,497 | 4,213 | 3,729 | 3,455 | 4,240 |
Cost of Revenue | |||||
Gross Profit | 987 | 1,645 | 1,162 | 865 | 1,199 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,506 | 2,314 | 3,176 | 3,260 | 3,438 |
Operating Profit | 991 | 1,899 | 554 | 195 | 801 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 964 | 1,799 | 469 | 107 | 709 |
Provision for Income Taxes | |||||
Net Income After Taxes | 717 | 1,252 | 219 | 30.6 | 415 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 719 | 1,342 | 221 | -605 | 416 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 719 | 1,342 | 221 | -605 | 416 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.331 | 0.656 | 0.324 | 0.225 | 0.369 |
Dividends per Share |